Aromatase inhibitors: potential reproductive implications.
作者： Mohamed A Bedaiwy , Noha A Mousa , Robert F Casper , None
DOI: 10.1016/J.JMIG.2009.05.009
关键词:
摘要: MEDLINE, EMBASE, Scopus, and Web of Science databases literature search from inception to March 2009 was performed identify published clinical trials cohort, observational, in vitro studies that evaluated the use aromatase inhibitors reproductive medicine for indications other than ovulation induction. Aromatase are currently being investigated breast cancer prevention women at high risk. may be used treatment symptomatic myomas endometriosis as an alternative surgical intervention. Current evidence does not support routine these conditions without prospective controlled trials. inhibitor cotreatment can prevent initial estrogen flare effect gonadotropin-releasing hormone agonist offer flexibility initiating this therapy.
elsevier.com
sci-hub.se 参考文章(92)
Paul Goss, The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial Current Oncology. ,vol. 14, pp. 89- 96 ,(2007) , 10.3747/CO.2007.117
Ronald A. Lubet, Gary J. Kelloff, Ernest T. Hawk, James A. Crowell, Karen Eisenhauer, Caroline C. Sigman, Vernon E. Steele, Charles W. Boone, Ronald Lieberman, Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 7, pp. 65- 78 ,(1998)
Joachim G. Liehr, Is estradiol a genotoxic mutagenic carcinogen Endocrine Reviews. ,vol. 21, pp. 40- 54 ,(2000) , 10.1210/EDRV.21.1.0386
Steven R. Cummings, Primary prevention of breast cancer: new approaches. Maturitas. ,vol. 57, pp. 39- 41 ,(2007) , 10.1016/J.MATURITAS.2007.02.010
L. Berstein, A. Kovalevskij, T. Zimarina, S. Maximov, E. Gershfeld, D. Vasilyev, S. Baisheva, A. Baymakhasheva, J.H.H. Thijssen, Aromatase and comparative response to its inhibitors in two types of endometrial cancer. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 95, pp. 71- 74 ,(2005) , 10.1016/J.JSBMB.2005.04.008
Noha A Mousa, Pavel Crystal, Wendy L Wolfman, Mohamed A Bedaiwy, Robert F Casper, None, Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause. ,vol. 15, pp. 875- 884 ,(2008) , 10.1097/GME.0B013E31816956C3
Donna Day Baird, David B. Dunson, Michael C. Hill, Deborah Cousins, Joel M. Schectman, High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence☆☆☆★ American Journal of Obstetrics and Gynecology. ,vol. 188, pp. 100- 107 ,(2003) , 10.1067/MOB.2003.99
Marie L. Misso, Christina Jang, Jennifer Adams, Jane Tran, Yoko Murata, Robin Bell, Wah Chin Boon, Evan R. Simpson, Susan R. Davis, Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause. ,vol. 12, pp. 210- 215 ,(2005) , 10.1097/00042192-200512020-00016
Shiuan Chen, Selma Masri, Xin Wang, Sheryl Phung, Yate-Ching Yuan, Xiwei Wu, What do we know about the mechanisms of aromatase inhibitor resistance? The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 102, pp. 232- 240 ,(2006) , 10.1016/J.JSBMB.2006.09.012
Richard Eastell, Rosemary Hannon, Long-term effects of aromatase inhibitors on bone. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 95, pp. 151- 154 ,(2005) , 10.1016/J.JSBMB.2005.04.009